Mission Wealth Management LP Raises Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Mission Wealth Management LP raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 20.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,022 shares of the financial services provider’s stock after purchasing an additional 506 shares during the quarter. Mission Wealth Management LP’s holdings in iShares Biotechnology ETF were worth $410,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Brookstone Capital Management increased its position in iShares Biotechnology ETF by 153.4% in the third quarter. Brookstone Capital Management now owns 6,484 shares of the financial services provider’s stock worth $763,000 after buying an additional 3,925 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in iShares Biotechnology ETF by 3.5% during the third quarter. Bank of New York Mellon Corp now owns 21,146 shares of the financial services provider’s stock valued at $2,586,000 after purchasing an additional 716 shares during the last quarter. Folger Nolan Fleming Douglas Capital Management Inc. boosted its position in iShares Biotechnology ETF by 1.0% during the third quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 67,830 shares of the financial services provider’s stock worth $8,295,000 after purchasing an additional 663 shares during the period. Macroview Investment Management LLC boosted its position in iShares Biotechnology ETF by 5,340.0% during the third quarter. Macroview Investment Management LLC now owns 544 shares of the financial services provider’s stock worth $67,000 after purchasing an additional 534 shares during the period. Finally, Park Avenue Securities LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth about $238,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $132.96 on Friday. The firm’s 50 day moving average is $133.61 and its 200 day moving average is $129.99. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.38%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.